Tylucyl 200 mg/mL Kroatien - kroatiska - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

tylucyl 200 mg/ml

vetoquinol sa, magny-vernois, 70200 lure, francuska - tilozin - otopina za injekciju - goveda, svinja

Acetilsalicilatna kiselina Bausch Health 100 mg želučanootporne tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

acetilsalicilatna kiselina bausch health 100 mg želučanootporne tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - acetilsalicilatna kiselina - želučanootporna tableta - urbroj: jedna želučanootporna tableta sadrži 100 mg acetilsalicilatne kiseline

Acetilsalicilatna kiselina Bausch Health 75 mg želučanootporne tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

acetilsalicilatna kiselina bausch health 75 mg želučanootporne tablete

bausch health ireland limited, 3013 lake drive, citywest business campus, dublin 24, irska - acetilsalicilatna kiselina - želučanootporna tableta - urbroj: jedna želučanootporna tableta sadrži 75 mg acetilsalicilatne kiseline

Jaglix 100 mg filmom obložene tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 100 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 100 mg sitagliptina

Jaglix 25 mg filmom obložene tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 25 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 25 mg sitagliptina

Jaglix 50 mg filmom obložene tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

jaglix 50 mg filmom obložene tablete

viatris limited, damastown industrial park, mulhuddart, dublin, irska - sitagliptinklorid hidrat - filmom obložena tableta - urbroj: jedna tableta sadrži sitagliptinklorid hidrat što odgovara 50 mg sitagliptina

Monkasta 10 mg filmom obložene tablete Kroatien - kroatiska - HALMED (Agencija za lijekove i medicinske proizvode)

monkasta 10 mg filmom obložene tablete

krka - farma d.o.o., radnička cesta 48, zagreb, hrvatska - montelukastnatrij - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 10 mg montelukasta u obliku montelukastnatrija

ASTMASAN 4 mg/1 kesica granule Bosnien och Hercegovina - kroatiska - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

astmasan 4 mg/1 kesica granule

novartis ba d.o.o. - montelukast - granule - 4 mg/1 kesica - 1 kesica sa granulama sadrži: 4 mg montelukasta ( u obliku montelukast natrijuma)

ASTMASAN 10 mg/1 tableta filmom obložena tableta Bosnien och Hercegovina - kroatiska - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

astmasan 10 mg/1 tableta filmom obložena tableta

novartis ba d.o.o. - montelukast - filmom obložena tableta - 10 mg/1 tableta - 1 filmom obložena tableta sadrži: 10 mg montelukasta (u obliku montelukastnatrijuma)

Rivaroxaban Viatris (previously Rivaroxaban Mylan) Europeiska unionen - kroatiska - EMA (European Medicines Agency)

rivaroxaban viatris (previously rivaroxaban mylan)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.